EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma

Xueqing Zou, Yongmei Wang, Mingyuan Luan, Yizheng Zhang

Frontiers in Pharmacology · 22.05.2025 · 16

DOI: 10.3389/fphar.2025.1605162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.05.2025. Verfasst von Xueqing Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatocellular carcinoma is a highly aggressive and heterogeneous malignancy with limited understanding of its heterogeneity.

Methods

In this study, we applied ten multi-omics classification algorithms to identify three distinct molecular subtypes of HCC (C1–C3). To further explore the immune microenvironment of these molecular subtypes, we leveraged single-cell transcriptomic data and employed CIBERSORTx to deconvolute their immune landscape.

Results

Among them, C3 exhibited the worst prognosis, whereas C1 and C2 were associated with relatively better clinical outcomes. Patients in the C3 group exhibited a high burden of copy number variations, mutation load, and methylation silencing. Our results revealed that compared to C1 and C2, C3 had a lower proportion of hepatocytes but a higher proportion of cholangiocytes and macrophages. Through analyses of hepatocyte, cholangiocyte, and macrophage subpopulations, we characterized their functional states, spatial distribution preferences, evolutionary relationships, and transcriptional regulatory networks, ultimately identifying cell subpopulations significantly associated with patient survival. Furthermore, we identified key ligand-receptor interactions, such as APOA1-TREM2 and APOA2-TREM2 in hepatocyte-macrophage crosstalk, and VTN-PLAUR in cholangiocyte-macrophage communication.

Discussion

Finally, we employed machine learning methods to construct a prognostic model for HCC patients and identified novel potential compounds for high risk patients. In summary, our novel multi-omics classification of HCC provides valuable insights into tumor heterogeneity and prognosis, offering potential clinical applications for precision oncology.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomamulti-omicsprecision oncologysingle-cell transcriptomicstumor heterogeneitytumor microenvironment

Autor:innen und Institutionen

  • Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
  • Breast Disease Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zou, X., Wang, Y., Luan, M., & Zhang, Y. (2025). Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1605162

Vancouver

Zou X, Wang Y, Luan M, Zhang Y. Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1605162

BibTeX
@article{Zou2025,
  author = {Zou, Xueqing and Wang, Yongmei and Luan, Mingyuan and Zhang, Yizheng},
  title = {Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1605162}
}
Kostenlos starten →